I'd be 100% confident NanoDiagnostics would be working 24/7 to get their NanoDX Covid19 solutioninto the market ASAP. Sharad Joshi, President & CEO of NanoDiagnostics, published a video 3 to 4 months ago talking about the incredible pivot the company had made to move from TBI to Covid19, and received plaudits from many. His credibility, and that of the company, are on the line. It could be argued that they have more at stake than Sensera as we have plenty of other projects in the pipeline.
From the NanoDiagnostics website, a reminder of how Sensera nanosensors are crtical to their solution
The breakthrough science integrated into the NanoDx™ System is based upon the revolutionary work of Nanosys, Inc., a pioneer of nanoscale technology. The patented nanosensor design includes an array of ultrasensitive nanowires that detect and measure specific biomarkers and infections in the bloodstream or other fluid specimens. The unique size and electrical properties of the nanosensors allow detection of biomarkers and infections never before possible in a simple, portable, point-of-care system.
I remain confident NanoDX will gain FDA EUA clearance. We just need to remain patient.
“Most people are too fretful, they worry too much. Success means being very patient, but aggressive when it’s time.” Charlie Munger
GLTAH. IMO
SE1 Price at posting:
6.8¢ Sentiment: Buy Disclosure: Held